Brief: Nykode Therapeutics Q3 Total Revenue And Other Income Down At USD 0.1 Mln
Nov 24 (Reuters) - Nykode Therapeutics ASA NYKD.OL: Q3 TOTAL REVENUE AND OTHER INCOME OF USD 0.1 MILLION Q3 NET LOSS OF USD 3.7 MILLION Source text: ID:nObimStHXa Further company coverage: NYKD.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Nykode Therapeutics ASA
See all newsRCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Brief: Nykode Therapeutics Mulls Private Placement
Brief: Nykode Receives Draft Recommendation In Tax Case
Brief: Nykode Therapeutics Receives U.S. Vaccine Patent
Brief: Nykode Therapeutics Expects Draft Recommendation From Norwegian Tax Appeal Board In August 2026